Tin tức & Cập nhật
Lọc theo Chuyên ngành:
NAFLD tied to CVD risk even in lean patients
Individuals with nonalcoholic fatty liver disease (NAFLD) – despite having a lean body or healthy BMI – are at an elevated risk for peripheral vascular disease, stroke, and cardiovascular disease (CVD), a finding that surprises gastroenterologists and researchers at DDW 2022.
NAFLD tied to CVD risk even in lean patients
06 Jun 2022Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation
Following discontinuation of nucleot(s)ide analogue therapy, only about one-third of patients with HBeAg-negative chronic hepatitis B (CHB) achieve disease remission, with rare HBsAg loss, as reported in a study. The likelihood of HBsAg loss and disease remission is high in the presence of very low HBsAg levels at baseline.
Very low HBsAg levels predict HBsAg loss, disease remission after therapy cessation
04 Jun 2022Statin use lowers all-cause mortality in colorectal cancer
Use of statins results in reduced all-cause mortality in nearly 30,000 veterans with colorectal cancer (CRC), results of a study have shown.
Statin use lowers all-cause mortality in colorectal cancer
03 Jun 2022Multivitamins help improve colorectal cancer survival
Patients who take multivitamin supplements at a moderate dose following their diagnosis of nonmetastatic colorectal cancer (CRC) appear to have a lower mortality, reports a recent study.
Multivitamins help improve colorectal cancer survival
02 Jun 2022Potty stool helps kids with functional constipation wean off medication
A defecation posture modification device (DPMD), also known as a potty stool, is both safe and beneficial for children with functional constipation (FC), helping them wean off pharmacotherapy and improving their bowel function, according to a study presented at the recently concluded 2022 Digestive Disease Week (DDW 2022).
Potty stool helps kids with functional constipation wean off medication
02 Jun 2022Antireflux mucosectomy effective against treatment-refractory GERD
Patients with treatment-refractory gastroesophageal reflux disease (GERD) may find relief from antireflux mucosectomy (ARMS), suggests a study.